Krebs Biochemicals & Industries Ltd. benchmarking: Performance to industry peers

Financial

	Krebs Biochem.&Inds	Alpa Laboratories	Kimia Biosciences
Operational Metrics
Financials
5 yr Average ROE	37.05 %	10.02 %	24.83 %
5yr average Equity Multiplier	-2.13	1.26	66.02
5yr Average Asset Turnover Ratio	0.3	0.62	1.14
5yr Avg Net Profit Margin	-55.19 %	13.26 %	-0.67 %
Price to Book	0.0	0.78	8.8
P/E	0.0	9.67	20.93
5yr Avg Cash Conversion Cycle	-1144.52 Days	114.37 Days	-33.97 Days
Inventory Days	102.59 Days	51.33 Days	101.63 Days
Days Receivable	8.23 Days	142.78 Days	98.68 Days
Days Payable	623.06 Days	94.49 Days	171.28 Days
5yr Average Interest Coverage Ratio	-4.97	94.43	0.78
5yr Avg ROCE	-23.43 %	13.16 %	10.6 %
5yr Avg Operating Profit Margin	-34.39 %	7.55 %	3.89 %
5 yr average Debt to Equity	-1.88	0.02	29.85
5yr CAGR Net Profit	-0.84 %	21.88 %	13.51 %
5yr Average Return on Assets	-16.47 %	7.94 %	-0.69 %
Shareholdings
Promoter Holding	72.74 %	57.19 %	74.94 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-0.1 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Krebs Biochem.&Inds	Alpa Laboratories	Kimia Biosciences
Product Wise Break-Up	Product Wise Break-Up Phenylephrine 62.86 Simvastatin 13.01 Sabam-RSS 0 Pharmaceuticals 0 Others 24.13	-	Product Wise Break-Up Simvastatin 0 Pharmaceutical 100.0 Phenylephrine 0 Sabam-RSS 0
Location Wise Break-Up	Location Wise Break-Up India 100.0 Rest of the World 0 International 0 Domestic 0	-	Location Wise Break-Up India 0 International 18.28 Rest of the World 0 Domestic 81.72
Therapeutic Area Break-Up	Therapeutic Area Break-Up Respiratory Systems 41.0 Cardiac Science 36.0 Others 23.0	-	-